Earnings Feed
Start Free
IMMUNE PHARMACEUTICALS INC·4

Oct 15, 5:13 PM ET

IMMUNE PHARMACEUTICALS INC 4

4 · IMMUNE PHARMACEUTICALS INC · Filed Oct 15, 2013

Insider Transaction Report

Form 4
Period: 2013-10-10
IMMUNE PHARMACEUTICALS INCIMNP
Stancic Ana
Director
Transactions
  • Award

    Stock Option (right to buy)

    2013-10-10+50,000→ 50,000 total
    Exercise: $2.50From: 2013-10-10Exp: 2023-10-09→ Common stock, par value $0.0001 (50,000 underlying)
  • Award

    Stock Option (right to buy)

    2013-10-10+50,000→ 50,000 total
    Exercise: $2.50Exp: 2023-10-09→ Common stock, par value $0.0001 (50,000 underlying)
Footnotes (3)
  • [F1]No consideration was given since option was granted pursuant to a stock option agreement.
  • [F2]Only represents the derivative securities of this class.
  • [F3]Shares vest quarterly over the next three years.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT